Search hospitals > Missouri > Kansas City
Research Medical Center
Claim this profileKansas City, Missouri 64132
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Leukemia
Conducts research for Recurrence
296 reported clinical trials
7 medical researchers
Summary
Research Medical Center is a medical facility located in Kansas City, Missouri. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Leukemia, Recurrence and other specialties. Research Medical Center is involved with conducting 296 clinical trials across 429 conditions. There are 7 research doctors associated with this hospital, such as Dhanunjaya Lakkireddy, Suman Kambhampati, Rakesh Gaur, and Kristopher LyBarger, DO.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Dhanunjaya LakkireddyKansas City Cardiac Arrhythmia Research Foundation2 years of reported clinical research
Expert in Atrial Fibrillation
Studies Cardiac Arrhythmias
23 reported clinical trials
23 drugs studied
Suman KambhampatiResearch Medical Center5 years of reported clinical research
Studies Lymphoma
Studies Leukemia
16 reported clinical trials
33 drugs studied
Rakesh GaurResearch Medical Center5 years of reported clinical research
Studies Breast Cancer
Studies Cancer
6 reported clinical trials
21 drugs studied
Kristopher LyBarger, DOHCA Midwest4 years of reported clinical research
Studies Ovarian Cancer
Studies Ovarian Tumors
3 reported clinical trials
7 drugs studied
Clinical Trials running at Research Medical Center
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Leukemia
Lymphoma
Lymphoid Leukemia
Cancer
Glioblastoma
Meningioma
Chronic B-Cell Leukemia
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Research Medical Center?
Research Medical Center is a medical facility located in Kansas City, Missouri. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Leukemia, Recurrence and other specialties. Research Medical Center is involved with conducting 296 clinical trials across 429 conditions. There are 7 research doctors associated with this hospital, such as Dhanunjaya Lakkireddy, Suman Kambhampati, Rakesh Gaur, and Kristopher LyBarger, DO.